Scholarship recipients each receive $1,000 for registration and travel to attend AcademyHealth’s Annual Research Achieving and the PHSR Curiosity Group Annual Meeting, June 27-June 30, 2010, in Boston. Scholarship winners shall present their analysis during a poster session in the PHSR Curiosity Group meeting. The following students received scholarships: Theresa Green, Western Michigan University; Justin Hall, University of Waterloo; Melissa Higdon, George Washington University; Judith Keagy, University of Arizona; Leesa Lin, Harvard School of General public Health; Elise Papke, University of Illinois at Chicago College of Public Health; Michael Preston, University of Arkansas for Medical Sciences; Vamsi Vasireddy, University of Illinois at Chicago; Nengliang Yao, Penn Condition University; and Ying Zhang, Georgetown University.The analysis found a significant increase in the expression of the enzyme and production of 12-HETE in humans with advanced-stage diabetic retinopathy and in pets with induced ischemic retinopathy. Al-Shabrawey treated retinal M-ller cells in vitro with 12-HETE also. He found this elevated the quantity of vascular endothelial growth factor and decreased pigment epithelium derived factor, disrupting the balance and resulting in neovascularization. Using this finding, Al-Shabrawey’s team found that treating the pets with an enzyme inhibitor or inducing ischemic retinopathy in animals lacking the enzyme restored that balance and inhibited neovascularization.